nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—migraine—Cyproheptadine—allergic rhinitis	0.38	1	CpDpCtD
Eletriptan—Clemastine—Cetirizine—allergic rhinitis	0.197	1	CrCrCtD
Eletriptan—HTR2B—Cyproheptadine—allergic rhinitis	0.0433	0.137	CbGbCtD
Eletriptan—HTR1A—Cyproheptadine—allergic rhinitis	0.0265	0.084	CbGbCtD
Eletriptan—CYP2A6—Montelukast—allergic rhinitis	0.0204	0.0644	CbGbCtD
Eletriptan—PTGS1—Diphenhydramine—allergic rhinitis	0.0174	0.055	CbGbCtD
Eletriptan—PTGS1—Montelukast—allergic rhinitis	0.0174	0.055	CbGbCtD
Eletriptan—CYP2C19—Desloratadine—allergic rhinitis	0.0147	0.0464	CbGbCtD
Eletriptan—CYP2C9—Desloratadine—allergic rhinitis	0.0122	0.0386	CbGbCtD
Eletriptan—CYP2A6—Prednisolone—allergic rhinitis	0.0119	0.0378	CbGbCtD
Eletriptan—ABCB1—Desloratadine—allergic rhinitis	0.0118	0.0374	CbGbCtD
Eletriptan—CYP2D6—Desloratadine—allergic rhinitis	0.0111	0.0353	CbGbCtD
Eletriptan—CYP2C19—Loratadine—allergic rhinitis	0.00842	0.0266	CbGbCtD
Eletriptan—CYP2C19—Diphenhydramine—allergic rhinitis	0.00842	0.0266	CbGbCtD
Eletriptan—CYP3A4—Flunisolide—allergic rhinitis	0.00709	0.0224	CbGbCtD
Eletriptan—CYP2A6—Dexamethasone—allergic rhinitis	0.00704	0.0223	CbGbCtD
Eletriptan—CYP2C9—Montelukast—allergic rhinitis	0.007	0.0221	CbGbCtD
Eletriptan—CYP2C9—Loratadine—allergic rhinitis	0.007	0.0221	CbGbCtD
Eletriptan—CYP2C9—Diphenhydramine—allergic rhinitis	0.007	0.0221	CbGbCtD
Eletriptan—ABCB1—Loratadine—allergic rhinitis	0.00679	0.0215	CbGbCtD
Eletriptan—CYP3A4—Olopatadine—allergic rhinitis	0.00666	0.0211	CbGbCtD
Eletriptan—CYP2D6—Loratadine—allergic rhinitis	0.0064	0.0203	CbGbCtD
Eletriptan—CYP2D6—Diphenhydramine—allergic rhinitis	0.0064	0.0203	CbGbCtD
Eletriptan—ABCB1—Methylprednisolone—allergic rhinitis	0.00621	0.0197	CbGbCtD
Eletriptan—CYP3A4—Montelukast—allergic rhinitis	0.00407	0.0129	CbGbCtD
Eletriptan—CYP3A4—Loratadine—allergic rhinitis	0.00407	0.0129	CbGbCtD
Eletriptan—ABCB1—Betamethasone—allergic rhinitis	0.00404	0.0128	CbGbCtD
Eletriptan—ABCB1—Prednisolone—allergic rhinitis	0.00399	0.0126	CbGbCtD
Eletriptan—ABCB1—Hydrocortisone—allergic rhinitis	0.00378	0.012	CbGbCtD
Eletriptan—CYP3A4—Methylprednisolone—allergic rhinitis	0.00372	0.0118	CbGbCtD
Eletriptan—CYP2C19—Dexamethasone—allergic rhinitis	0.00291	0.00922	CbGbCtD
Eletriptan—CYP3A4—Triamcinolone—allergic rhinitis	0.00282	0.00893	CbGbCtD
Eletriptan—CYP2C9—Dexamethasone—allergic rhinitis	0.00242	0.00766	CbGbCtD
Eletriptan—CYP3A4—Betamethasone—allergic rhinitis	0.00242	0.00766	CbGbCtD
Eletriptan—CYP3A4—Prednisolone—allergic rhinitis	0.00239	0.00756	CbGbCtD
Eletriptan—ABCB1—Dexamethasone—allergic rhinitis	0.00235	0.00744	CbGbCtD
Eletriptan—CYP3A4—Hydrocortisone—allergic rhinitis	0.00226	0.00716	CbGbCtD
Eletriptan—CYP2D6—Dexamethasone—allergic rhinitis	0.00221	0.00701	CbGbCtD
Eletriptan—CYP3A4—Dexamethasone—allergic rhinitis	0.00141	0.00445	CbGbCtD
Eletriptan—HTR1F—G alpha (i) signalling events—PTGDR2—allergic rhinitis	7.88e-05	0.0181	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—PTGDR2—allergic rhinitis	7.43e-05	0.017	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	7.31e-05	0.0168	CbGpPWpGaD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	6.9e-05	0.0158	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	6.26e-05	0.0144	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	5.91e-05	0.0135	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	5.74e-05	0.0132	CbGpPWpGaD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	5.41e-05	0.0124	CbGpPWpGaD
Eletriptan—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	5.39e-05	0.0124	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—PTGDR2—allergic rhinitis	5.04e-05	0.0116	CbGpPWpGaD
Eletriptan—HTR1B—G alpha (i) signalling events—PTGDR2—allergic rhinitis	4.93e-05	0.0113	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	4.92e-05	0.0113	CbGpPWpGaD
Eletriptan—Conjunctivitis—Betamethasone—allergic rhinitis	4.84e-05	0.000473	CcSEcCtD
Eletriptan—Conjunctivitis—Dexamethasone—allergic rhinitis	4.84e-05	0.000473	CcSEcCtD
Eletriptan—Nausea—Flunisolide—allergic rhinitis	4.79e-05	0.000469	CcSEcCtD
Eletriptan—Arrhythmia—Prednisolone—allergic rhinitis	4.79e-05	0.000468	CcSEcCtD
Eletriptan—HTR1F—GPCR ligand binding—PTGDR2—allergic rhinitis	4.77e-05	0.0109	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	4.75e-05	0.0109	CbGpPWpGaD
Eletriptan—Visual impairment—Methylprednisolone—allergic rhinitis	4.74e-05	0.000463	CcSEcCtD
Eletriptan—Immune system disorder—Hydrocortisone—allergic rhinitis	4.73e-05	0.000462	CcSEcCtD
Eletriptan—Diarrhoea—Montelukast—allergic rhinitis	4.71e-05	0.00046	CcSEcCtD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	4.71e-05	0.0108	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	4.68e-05	0.0107	CbGpPWpGaD
Eletriptan—Arrhythmia—Hydrocortisone—allergic rhinitis	4.67e-05	0.000457	CcSEcCtD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	4.64e-05	0.0106	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	4.58e-05	0.0105	CbGpPWpGaD
Eletriptan—Dizziness—Montelukast—allergic rhinitis	4.55e-05	0.000445	CcSEcCtD
Eletriptan—Bradycardia—Dexamethasone—allergic rhinitis	4.55e-05	0.000445	CcSEcCtD
Eletriptan—Bradycardia—Betamethasone—allergic rhinitis	4.55e-05	0.000445	CcSEcCtD
Eletriptan—HTR1E—GPCR ligand binding—PTGDR2—allergic rhinitis	4.5e-05	0.0103	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	4.48e-05	0.0103	CbGpPWpGaD
Eletriptan—Hallucination—Dexamethasone—allergic rhinitis	4.45e-05	0.000435	CcSEcCtD
Eletriptan—Hallucination—Betamethasone—allergic rhinitis	4.45e-05	0.000435	CcSEcCtD
Eletriptan—Immune system disorder—Methylprednisolone—allergic rhinitis	4.44e-05	0.000434	CcSEcCtD
Eletriptan—Arrhythmia—Triamcinolone—allergic rhinitis	4.4e-05	0.00043	CcSEcCtD
Eletriptan—Arrhythmia—Methylprednisolone—allergic rhinitis	4.39e-05	0.000429	CcSEcCtD
Eletriptan—Vomiting—Montelukast—allergic rhinitis	4.38e-05	0.000428	CcSEcCtD
Eletriptan—HTR2B—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	4.37e-05	0.01	CbGpPWpGaD
Eletriptan—Rash—Montelukast—allergic rhinitis	4.34e-05	0.000424	CcSEcCtD
Eletriptan—Dermatitis—Montelukast—allergic rhinitis	4.34e-05	0.000424	CcSEcCtD
Eletriptan—Ill-defined disorder—Prednisolone—allergic rhinitis	4.33e-05	0.000423	CcSEcCtD
Eletriptan—Headache—Montelukast—allergic rhinitis	4.31e-05	0.000422	CcSEcCtD
Eletriptan—Visual impairment—Betamethasone—allergic rhinitis	4.31e-05	0.000421	CcSEcCtD
Eletriptan—Visual impairment—Dexamethasone—allergic rhinitis	4.31e-05	0.000421	CcSEcCtD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	4.3e-05	0.00986	CbGpPWpGaD
Eletriptan—Angioedema—Prednisolone—allergic rhinitis	4.26e-05	0.000417	CcSEcCtD
Eletriptan—Ill-defined disorder—Hydrocortisone—allergic rhinitis	4.23e-05	0.000413	CcSEcCtD
Eletriptan—Malaise—Prednisolone—allergic rhinitis	4.21e-05	0.000411	CcSEcCtD
Eletriptan—Dysgeusia—Triamcinolone—allergic rhinitis	4.2e-05	0.000411	CcSEcCtD
Eletriptan—Vertigo—Prednisolone—allergic rhinitis	4.19e-05	0.00041	CcSEcCtD
Eletriptan—Syncope—Prednisolone—allergic rhinitis	4.18e-05	0.000409	CcSEcCtD
Eletriptan—Angioedema—Hydrocortisone—allergic rhinitis	4.16e-05	0.000407	CcSEcCtD
Eletriptan—Back pain—Triamcinolone—allergic rhinitis	4.15e-05	0.000406	CcSEcCtD
Eletriptan—Malaise—Hydrocortisone—allergic rhinitis	4.11e-05	0.000402	CcSEcCtD
Eletriptan—Loss of consciousness—Prednisolone—allergic rhinitis	4.1e-05	0.000401	CcSEcCtD
Eletriptan—Vertigo—Hydrocortisone—allergic rhinitis	4.09e-05	0.0004	CcSEcCtD
Eletriptan—Nausea—Montelukast—allergic rhinitis	4.09e-05	0.0004	CcSEcCtD
Eletriptan—Syncope—Hydrocortisone—allergic rhinitis	4.08e-05	0.000399	CcSEcCtD
Eletriptan—Convulsion—Prednisolone—allergic rhinitis	4.04e-05	0.000395	CcSEcCtD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	4.03e-05	0.00924	CbGpPWpGaD
Eletriptan—Hypertension—Prednisolone—allergic rhinitis	4.03e-05	0.000394	CcSEcCtD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	4.01e-05	0.00918	CbGpPWpGaD
Eletriptan—Loss of consciousness—Hydrocortisone—allergic rhinitis	4e-05	0.000391	CcSEcCtD
Eletriptan—Arrhythmia—Betamethasone—allergic rhinitis	3.99e-05	0.00039	CcSEcCtD
Eletriptan—Arrhythmia—Dexamethasone—allergic rhinitis	3.99e-05	0.00039	CcSEcCtD
Eletriptan—Ill-defined disorder—Triamcinolone—allergic rhinitis	3.98e-05	0.000389	CcSEcCtD
Eletriptan—Ill-defined disorder—Methylprednisolone—allergic rhinitis	3.97e-05	0.000388	CcSEcCtD
Eletriptan—Alopecia—Dexamethasone—allergic rhinitis	3.95e-05	0.000386	CcSEcCtD
Eletriptan—Alopecia—Betamethasone—allergic rhinitis	3.95e-05	0.000386	CcSEcCtD
Eletriptan—Convulsion—Hydrocortisone—allergic rhinitis	3.95e-05	0.000386	CcSEcCtD
Eletriptan—Hypertension—Hydrocortisone—allergic rhinitis	3.93e-05	0.000384	CcSEcCtD
Eletriptan—Discomfort—Prednisolone—allergic rhinitis	3.92e-05	0.000383	CcSEcCtD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	3.92e-05	0.00899	CbGpPWpGaD
Eletriptan—Angioedema—Triamcinolone—allergic rhinitis	3.92e-05	0.000383	CcSEcCtD
Eletriptan—Angioedema—Methylprednisolone—allergic rhinitis	3.91e-05	0.000382	CcSEcCtD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	3.9e-05	0.00895	CbGpPWpGaD
Eletriptan—Myalgia—Hydrocortisone—allergic rhinitis	3.88e-05	0.000379	CcSEcCtD
Eletriptan—Malaise—Triamcinolone—allergic rhinitis	3.87e-05	0.000378	CcSEcCtD
Eletriptan—Anxiety—Hydrocortisone—allergic rhinitis	3.86e-05	0.000378	CcSEcCtD
Eletriptan—Malaise—Methylprednisolone—allergic rhinitis	3.86e-05	0.000377	CcSEcCtD
Eletriptan—Vertigo—Triamcinolone—allergic rhinitis	3.85e-05	0.000377	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	3.85e-05	0.000376	CcSEcCtD
Eletriptan—Syncope—Triamcinolone—allergic rhinitis	3.85e-05	0.000376	CcSEcCtD
Eletriptan—Vertigo—Methylprednisolone—allergic rhinitis	3.84e-05	0.000376	CcSEcCtD
Eletriptan—Syncope—Methylprednisolone—allergic rhinitis	3.84e-05	0.000375	CcSEcCtD
Eletriptan—Discomfort—Hydrocortisone—allergic rhinitis	3.83e-05	0.000375	CcSEcCtD
Eletriptan—Oedema—Prednisolone—allergic rhinitis	3.81e-05	0.000372	CcSEcCtD
Eletriptan—Loss of consciousness—Triamcinolone—allergic rhinitis	3.77e-05	0.000368	CcSEcCtD
Eletriptan—Loss of consciousness—Methylprednisolone—allergic rhinitis	3.76e-05	0.000368	CcSEcCtD
Eletriptan—HTR1A—G alpha (i) signalling events—PTGDR2—allergic rhinitis	3.76e-05	0.00862	CbGpPWpGaD
Eletriptan—Shock—Prednisolone—allergic rhinitis	3.74e-05	0.000366	CcSEcCtD
Eletriptan—HTR1F—GPCR ligand binding—CYSLTR1—allergic rhinitis	3.74e-05	0.00858	CbGpPWpGaD
Eletriptan—Cough—Triamcinolone—allergic rhinitis	3.74e-05	0.000366	CcSEcCtD
Eletriptan—Oedema—Hydrocortisone—allergic rhinitis	3.72e-05	0.000363	CcSEcCtD
Eletriptan—Convulsion—Triamcinolone—allergic rhinitis	3.72e-05	0.000363	CcSEcCtD
Eletriptan—Tachycardia—Prednisolone—allergic rhinitis	3.71e-05	0.000363	CcSEcCtD
Eletriptan—Convulsion—Methylprednisolone—allergic rhinitis	3.71e-05	0.000362	CcSEcCtD
Eletriptan—Hypertension—Triamcinolone—allergic rhinitis	3.7e-05	0.000362	CcSEcCtD
Eletriptan—Hypertension—Methylprednisolone—allergic rhinitis	3.69e-05	0.000361	CcSEcCtD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	3.69e-05	0.00847	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	3.68e-05	0.00845	CbGpPWpGaD
Eletriptan—Hyperhidrosis—Prednisolone—allergic rhinitis	3.68e-05	0.00036	CcSEcCtD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	3.67e-05	0.00841	CbGpPWpGaD
Eletriptan—Shock—Hydrocortisone—allergic rhinitis	3.66e-05	0.000357	CcSEcCtD
Eletriptan—Myalgia—Triamcinolone—allergic rhinitis	3.65e-05	0.000357	CcSEcCtD
Eletriptan—Nervous system disorder—Hydrocortisone—allergic rhinitis	3.65e-05	0.000356	CcSEcCtD
Eletriptan—Arthralgia—Methylprednisolone—allergic rhinitis	3.64e-05	0.000356	CcSEcCtD
Eletriptan—Myalgia—Methylprednisolone—allergic rhinitis	3.64e-05	0.000356	CcSEcCtD
Eletriptan—Anxiety—Methylprednisolone—allergic rhinitis	3.63e-05	0.000355	CcSEcCtD
Eletriptan—Tachycardia—Hydrocortisone—allergic rhinitis	3.63e-05	0.000355	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	3.62e-05	0.000354	CcSEcCtD
Eletriptan—HTR1F—GPCR ligand binding—CCL11—allergic rhinitis	3.62e-05	0.00829	CbGpPWpGaD
Eletriptan—Skin disorder—Hydrocortisone—allergic rhinitis	3.61e-05	0.000353	CcSEcCtD
Eletriptan—Ill-defined disorder—Dexamethasone—allergic rhinitis	3.61e-05	0.000353	CcSEcCtD
Eletriptan—Ill-defined disorder—Betamethasone—allergic rhinitis	3.61e-05	0.000353	CcSEcCtD
Eletriptan—Discomfort—Triamcinolone—allergic rhinitis	3.61e-05	0.000353	CcSEcCtD
Eletriptan—Discomfort—Methylprednisolone—allergic rhinitis	3.6e-05	0.000352	CcSEcCtD
Eletriptan—Hyperhidrosis—Hydrocortisone—allergic rhinitis	3.59e-05	0.000351	CcSEcCtD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	3.59e-05	0.00824	CbGpPWpGaD
Eletriptan—Dry mouth—Triamcinolone—allergic rhinitis	3.57e-05	0.000349	CcSEcCtD
Eletriptan—Angioedema—Dexamethasone—allergic rhinitis	3.56e-05	0.000348	CcSEcCtD
Eletriptan—Angioedema—Betamethasone—allergic rhinitis	3.56e-05	0.000348	CcSEcCtD
Eletriptan—Anorexia—Hydrocortisone—allergic rhinitis	3.54e-05	0.000346	CcSEcCtD
Eletriptan—HTR1E—GPCR ligand binding—CYSLTR1—allergic rhinitis	3.53e-05	0.00809	CbGpPWpGaD
Eletriptan—Confusional state—Methylprednisolone—allergic rhinitis	3.52e-05	0.000344	CcSEcCtD
Eletriptan—Malaise—Dexamethasone—allergic rhinitis	3.51e-05	0.000343	CcSEcCtD
Eletriptan—Malaise—Betamethasone—allergic rhinitis	3.51e-05	0.000343	CcSEcCtD
Eletriptan—Oedema—Triamcinolone—allergic rhinitis	3.5e-05	0.000342	CcSEcCtD
Eletriptan—Vertigo—Betamethasone—allergic rhinitis	3.5e-05	0.000342	CcSEcCtD
Eletriptan—Vertigo—Dexamethasone—allergic rhinitis	3.5e-05	0.000342	CcSEcCtD
Eletriptan—Syncope—Betamethasone—allergic rhinitis	3.49e-05	0.000341	CcSEcCtD
Eletriptan—Syncope—Dexamethasone—allergic rhinitis	3.49e-05	0.000341	CcSEcCtD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	3.49e-05	0.008	CbGpPWpGaD
Eletriptan—Hypotension—Hydrocortisone—allergic rhinitis	3.47e-05	0.00034	CcSEcCtD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	3.45e-05	0.00791	CbGpPWpGaD
Eletriptan—Shock—Triamcinolone—allergic rhinitis	3.44e-05	0.000337	CcSEcCtD
Eletriptan—Insomnia—Prednisolone—allergic rhinitis	3.44e-05	0.000337	CcSEcCtD
Eletriptan—Shock—Methylprednisolone—allergic rhinitis	3.44e-05	0.000336	CcSEcCtD
Eletriptan—Nervous system disorder—Methylprednisolone—allergic rhinitis	3.42e-05	0.000335	CcSEcCtD
Eletriptan—Loss of consciousness—Dexamethasone—allergic rhinitis	3.42e-05	0.000334	CcSEcCtD
Eletriptan—Loss of consciousness—Betamethasone—allergic rhinitis	3.42e-05	0.000334	CcSEcCtD
Eletriptan—Paraesthesia—Prednisolone—allergic rhinitis	3.42e-05	0.000334	CcSEcCtD
Eletriptan—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	3.42e-05	0.00783	CbGpPWpGaD
Eletriptan—Tachycardia—Triamcinolone—allergic rhinitis	3.42e-05	0.000334	CcSEcCtD
Eletriptan—HTR1E—GPCR ligand binding—CCL11—allergic rhinitis	3.41e-05	0.00782	CbGpPWpGaD
Eletriptan—Tachycardia—Methylprednisolone—allergic rhinitis	3.41e-05	0.000333	CcSEcCtD
Eletriptan—Skin disorder—Methylprednisolone—allergic rhinitis	3.39e-05	0.000332	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	3.39e-05	0.000331	CcSEcCtD
Eletriptan—Hyperhidrosis—Triamcinolone—allergic rhinitis	3.38e-05	0.000331	CcSEcCtD
Eletriptan—Hyperhidrosis—Methylprednisolone—allergic rhinitis	3.38e-05	0.00033	CcSEcCtD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	3.37e-05	0.00774	CbGpPWpGaD
Eletriptan—Convulsion—Dexamethasone—allergic rhinitis	3.37e-05	0.00033	CcSEcCtD
Eletriptan—Convulsion—Betamethasone—allergic rhinitis	3.37e-05	0.00033	CcSEcCtD
Eletriptan—Insomnia—Hydrocortisone—allergic rhinitis	3.36e-05	0.000329	CcSEcCtD
Eletriptan—Hypertension—Dexamethasone—allergic rhinitis	3.36e-05	0.000328	CcSEcCtD
Eletriptan—Hypertension—Betamethasone—allergic rhinitis	3.36e-05	0.000328	CcSEcCtD
Eletriptan—Paraesthesia—Hydrocortisone—allergic rhinitis	3.34e-05	0.000326	CcSEcCtD
Eletriptan—Myalgia—Betamethasone—allergic rhinitis	3.31e-05	0.000324	CcSEcCtD
Eletriptan—Myalgia—Dexamethasone—allergic rhinitis	3.31e-05	0.000324	CcSEcCtD
Eletriptan—Anxiety—Betamethasone—allergic rhinitis	3.3e-05	0.000323	CcSEcCtD
Eletriptan—Anxiety—Dexamethasone—allergic rhinitis	3.3e-05	0.000323	CcSEcCtD
Eletriptan—Discomfort—Betamethasone—allergic rhinitis	3.27e-05	0.00032	CcSEcCtD
Eletriptan—Discomfort—Dexamethasone—allergic rhinitis	3.27e-05	0.00032	CcSEcCtD
Eletriptan—Dyspepsia—Hydrocortisone—allergic rhinitis	3.27e-05	0.00032	CcSEcCtD
Eletriptan—Hypotension—Methylprednisolone—allergic rhinitis	3.26e-05	0.000319	CcSEcCtD
Eletriptan—Pain—Prednisolone—allergic rhinitis	3.25e-05	0.000318	CcSEcCtD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	3.25e-05	0.00746	CbGpPWpGaD
Eletriptan—Decreased appetite—Hydrocortisone—allergic rhinitis	3.23e-05	0.000316	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	3.21e-05	0.000314	CcSEcCtD
Eletriptan—Fatigue—Hydrocortisone—allergic rhinitis	3.2e-05	0.000313	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	3.19e-05	0.000312	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	3.18e-05	0.000311	CcSEcCtD
Eletriptan—Pain—Hydrocortisone—allergic rhinitis	3.18e-05	0.000311	CcSEcCtD
Eletriptan—Oedema—Betamethasone—allergic rhinitis	3.18e-05	0.00031	CcSEcCtD
Eletriptan—Oedema—Dexamethasone—allergic rhinitis	3.18e-05	0.00031	CcSEcCtD
Eletriptan—Insomnia—Triamcinolone—allergic rhinitis	3.17e-05	0.000309	CcSEcCtD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	3.16e-05	0.00725	CbGpPWpGaD
Eletriptan—Insomnia—Methylprednisolone—allergic rhinitis	3.16e-05	0.000309	CcSEcCtD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	3.14e-05	0.00721	CbGpPWpGaD
Eletriptan—Paraesthesia—Triamcinolone—allergic rhinitis	3.14e-05	0.000307	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisolone—allergic rhinitis	3.14e-05	0.000307	CcSEcCtD
Eletriptan—Paraesthesia—Methylprednisolone—allergic rhinitis	3.14e-05	0.000307	CcSEcCtD
Eletriptan—Shock—Betamethasone—allergic rhinitis	3.12e-05	0.000305	CcSEcCtD
Eletriptan—Shock—Dexamethasone—allergic rhinitis	3.12e-05	0.000305	CcSEcCtD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—IL13—allergic rhinitis	3.12e-05	0.00715	CbGpPWpGaD
Eletriptan—Dyspnoea—Triamcinolone—allergic rhinitis	3.12e-05	0.000305	CcSEcCtD
Eletriptan—Nervous system disorder—Dexamethasone—allergic rhinitis	3.11e-05	0.000304	CcSEcCtD
Eletriptan—Nervous system disorder—Betamethasone—allergic rhinitis	3.11e-05	0.000304	CcSEcCtD
Eletriptan—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	3.1e-05	0.00711	CbGpPWpGaD
Eletriptan—Tachycardia—Dexamethasone—allergic rhinitis	3.1e-05	0.000303	CcSEcCtD
Eletriptan—Tachycardia—Betamethasone—allergic rhinitis	3.1e-05	0.000303	CcSEcCtD
Eletriptan—Dyspepsia—Triamcinolone—allergic rhinitis	3.08e-05	0.000301	CcSEcCtD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	3.08e-05	0.00706	CbGpPWpGaD
Eletriptan—Dyspepsia—Methylprednisolone—allergic rhinitis	3.07e-05	0.000301	CcSEcCtD
Eletriptan—HTR7—GPCR ligand binding—PTGDR2—allergic rhinitis	3.07e-05	0.00704	CbGpPWpGaD
Eletriptan—Hyperhidrosis—Betamethasone—allergic rhinitis	3.07e-05	0.0003	CcSEcCtD
Eletriptan—Hyperhidrosis—Dexamethasone—allergic rhinitis	3.07e-05	0.0003	CcSEcCtD
Eletriptan—HTR2B—G alpha (q) signalling events—TAC1—allergic rhinitis	3.06e-05	0.00702	CbGpPWpGaD
Eletriptan—Feeling abnormal—Hydrocortisone—allergic rhinitis	3.06e-05	0.000299	CcSEcCtD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	3.06e-05	0.00701	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—PTGDR2—allergic rhinitis	3.05e-05	0.00699	CbGpPWpGaD
Eletriptan—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	3.04e-05	0.000297	CcSEcCtD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	3.04e-05	0.00696	CbGpPWpGaD
Eletriptan—Anorexia—Betamethasone—allergic rhinitis	3.03e-05	0.000296	CcSEcCtD
Eletriptan—Anorexia—Dexamethasone—allergic rhinitis	3.03e-05	0.000296	CcSEcCtD
Eletriptan—Urticaria—Prednisolone—allergic rhinitis	3.02e-05	0.000296	CcSEcCtD
Eletriptan—Fatigue—Triamcinolone—allergic rhinitis	3.02e-05	0.000295	CcSEcCtD
Eletriptan—Fatigue—Methylprednisolone—allergic rhinitis	3.01e-05	0.000294	CcSEcCtD
Eletriptan—Pain—Triamcinolone—allergic rhinitis	2.99e-05	0.000293	CcSEcCtD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.99e-05	0.00685	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—PTGDR2—allergic rhinitis	2.99e-05	0.00685	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	2.97e-05	0.00681	CbGpPWpGaD
Eletriptan—Hypotension—Betamethasone—allergic rhinitis	2.97e-05	0.00029	CcSEcCtD
Eletriptan—Hypotension—Dexamethasone—allergic rhinitis	2.97e-05	0.00029	CcSEcCtD
Eletriptan—Urticaria—Hydrocortisone—allergic rhinitis	2.95e-05	0.000289	CcSEcCtD
Eletriptan—Abdominal pain—Hydrocortisone—allergic rhinitis	2.94e-05	0.000287	CcSEcCtD
Eletriptan—Body temperature increased—Hydrocortisone—allergic rhinitis	2.94e-05	0.000287	CcSEcCtD
Eletriptan—ABCB1—Allograft Rejection—IL13—allergic rhinitis	2.92e-05	0.0067	CbGpPWpGaD
Eletriptan—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	2.89e-05	0.000283	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	2.89e-05	0.000283	CcSEcCtD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	2.89e-05	0.00663	CbGpPWpGaD
Eletriptan—Feeling abnormal—Triamcinolone—allergic rhinitis	2.88e-05	0.000282	CcSEcCtD
Eletriptan—Feeling abnormal—Methylprednisolone—allergic rhinitis	2.88e-05	0.000281	CcSEcCtD
Eletriptan—Insomnia—Betamethasone—allergic rhinitis	2.87e-05	0.000281	CcSEcCtD
Eletriptan—Insomnia—Dexamethasone—allergic rhinitis	2.87e-05	0.000281	CcSEcCtD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	2.87e-05	0.00658	CbGpPWpGaD
Eletriptan—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	2.86e-05	0.000279	CcSEcCtD
Eletriptan—Paraesthesia—Betamethasone—allergic rhinitis	2.85e-05	0.000279	CcSEcCtD
Eletriptan—Paraesthesia—Dexamethasone—allergic rhinitis	2.85e-05	0.000279	CcSEcCtD
Eletriptan—HTR7—Circadian rythm related genes—ADIPOQ—allergic rhinitis	2.85e-05	0.00653	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—PTGDR2—allergic rhinitis	2.81e-05	0.00643	CbGpPWpGaD
Eletriptan—Hypersensitivity—Prednisolone—allergic rhinitis	2.8e-05	0.000274	CcSEcCtD
Eletriptan—Dyspepsia—Betamethasone—allergic rhinitis	2.8e-05	0.000273	CcSEcCtD
Eletriptan—Dyspepsia—Dexamethasone—allergic rhinitis	2.8e-05	0.000273	CcSEcCtD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	2.79e-05	0.0064	CbGpPWpGaD
Eletriptan—Urticaria—Triamcinolone—allergic rhinitis	2.78e-05	0.000272	CcSEcCtD
Eletriptan—Urticaria—Methylprednisolone—allergic rhinitis	2.77e-05	0.000271	CcSEcCtD
Eletriptan—Body temperature increased—Triamcinolone—allergic rhinitis	2.77e-05	0.00027	CcSEcCtD
Eletriptan—Abdominal pain—Methylprednisolone—allergic rhinitis	2.76e-05	0.00027	CcSEcCtD
Eletriptan—Decreased appetite—Dexamethasone—allergic rhinitis	2.76e-05	0.00027	CcSEcCtD
Eletriptan—Decreased appetite—Betamethasone—allergic rhinitis	2.76e-05	0.00027	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Betamethasone—allergic rhinitis	2.74e-05	0.000268	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	2.74e-05	0.000268	CcSEcCtD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	2.74e-05	0.00628	CbGpPWpGaD
Eletriptan—Hypersensitivity—Hydrocortisone—allergic rhinitis	2.74e-05	0.000268	CcSEcCtD
Eletriptan—Fatigue—Dexamethasone—allergic rhinitis	2.74e-05	0.000268	CcSEcCtD
Eletriptan—Fatigue—Betamethasone—allergic rhinitis	2.74e-05	0.000268	CcSEcCtD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	2.74e-05	0.00627	CbGpPWpGaD
Eletriptan—Pain—Betamethasone—allergic rhinitis	2.72e-05	0.000265	CcSEcCtD
Eletriptan—Pain—Dexamethasone—allergic rhinitis	2.72e-05	0.000265	CcSEcCtD
Eletriptan—HTR1F—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.7e-05	0.00618	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	2.69e-05	0.00617	CbGpPWpGaD
Eletriptan—Asthenia—Hydrocortisone—allergic rhinitis	2.67e-05	0.000261	CcSEcCtD
Eletriptan—Pruritus—Hydrocortisone—allergic rhinitis	2.63e-05	0.000257	CcSEcCtD
Eletriptan—HTR1F—GPCR ligand binding—TAC1—allergic rhinitis	2.63e-05	0.00602	CbGpPWpGaD
Eletriptan—Feeling abnormal—Dexamethasone—allergic rhinitis	2.62e-05	0.000256	CcSEcCtD
Eletriptan—Feeling abnormal—Betamethasone—allergic rhinitis	2.62e-05	0.000256	CcSEcCtD
Eletriptan—Gastrointestinal pain—Dexamethasone—allergic rhinitis	2.6e-05	0.000254	CcSEcCtD
Eletriptan—Gastrointestinal pain—Betamethasone—allergic rhinitis	2.6e-05	0.000254	CcSEcCtD
Eletriptan—Hypersensitivity—Triamcinolone—allergic rhinitis	2.58e-05	0.000252	CcSEcCtD
Eletriptan—Hypersensitivity—Methylprednisolone—allergic rhinitis	2.57e-05	0.000252	CcSEcCtD
Eletriptan—Diarrhoea—Hydrocortisone—allergic rhinitis	2.54e-05	0.000249	CcSEcCtD
Eletriptan—HTR1E—GPCR downstream signaling—PTGDR2—allergic rhinitis	2.54e-05	0.00583	CbGpPWpGaD
Eletriptan—Urticaria—Dexamethasone—allergic rhinitis	2.52e-05	0.000247	CcSEcCtD
Eletriptan—Urticaria—Betamethasone—allergic rhinitis	2.52e-05	0.000247	CcSEcCtD
Eletriptan—Dizziness—Prednisolone—allergic rhinitis	2.52e-05	0.000246	CcSEcCtD
Eletriptan—Asthenia—Triamcinolone—allergic rhinitis	2.51e-05	0.000245	CcSEcCtD
Eletriptan—Body temperature increased—Dexamethasone—allergic rhinitis	2.51e-05	0.000245	CcSEcCtD
Eletriptan—Abdominal pain—Dexamethasone—allergic rhinitis	2.51e-05	0.000245	CcSEcCtD
Eletriptan—Abdominal pain—Betamethasone—allergic rhinitis	2.51e-05	0.000245	CcSEcCtD
Eletriptan—Body temperature increased—Betamethasone—allergic rhinitis	2.51e-05	0.000245	CcSEcCtD
Eletriptan—Asthenia—Methylprednisolone—allergic rhinitis	2.51e-05	0.000245	CcSEcCtD
Eletriptan—ABCB1—Allograft Rejection—IL5—allergic rhinitis	2.5e-05	0.00573	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—TAC1—allergic rhinitis	2.48e-05	0.00568	CbGpPWpGaD
Eletriptan—Pruritus—Triamcinolone—allergic rhinitis	2.48e-05	0.000242	CcSEcCtD
Eletriptan—Pruritus—Methylprednisolone—allergic rhinitis	2.47e-05	0.000242	CcSEcCtD
Eletriptan—Dizziness—Hydrocortisone—allergic rhinitis	2.46e-05	0.00024	CcSEcCtD
Eletriptan—HTR1F—Signaling by GPCR—PTGDR2—allergic rhinitis	2.45e-05	0.00561	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—CYSLTR1—allergic rhinitis	2.41e-05	0.00552	CbGpPWpGaD
Eletriptan—Rash—Prednisolone—allergic rhinitis	2.4e-05	0.000235	CcSEcCtD
Eletriptan—Dermatitis—Prednisolone—allergic rhinitis	2.4e-05	0.000234	CcSEcCtD
Eletriptan—HTR1D—GPCR ligand binding—CYSLTR1—allergic rhinitis	2.39e-05	0.00549	CbGpPWpGaD
Eletriptan—Diarrhoea—Methylprednisolone—allergic rhinitis	2.39e-05	0.000234	CcSEcCtD
Eletriptan—Headache—Prednisolone—allergic rhinitis	2.38e-05	0.000233	CcSEcCtD
Eletriptan—Vomiting—Hydrocortisone—allergic rhinitis	2.36e-05	0.000231	CcSEcCtD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	2.34e-05	0.00538	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—CYSLTR1—allergic rhinitis	2.34e-05	0.00537	CbGpPWpGaD
Eletriptan—Rash—Hydrocortisone—allergic rhinitis	2.34e-05	0.000229	CcSEcCtD
Eletriptan—Dermatitis—Hydrocortisone—allergic rhinitis	2.34e-05	0.000229	CcSEcCtD
Eletriptan—Headache—Hydrocortisone—allergic rhinitis	2.33e-05	0.000228	CcSEcCtD
Eletriptan—HTR7—GPCR ligand binding—CCL11—allergic rhinitis	2.33e-05	0.00533	CbGpPWpGaD
Eletriptan—Dizziness—Triamcinolone—allergic rhinitis	2.31e-05	0.000226	CcSEcCtD
Eletriptan—HTR1D—GPCR ligand binding—CCL11—allergic rhinitis	2.31e-05	0.0053	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—PTGDR2—allergic rhinitis	2.31e-05	0.00529	CbGpPWpGaD
Eletriptan—Dizziness—Methylprednisolone—allergic rhinitis	2.31e-05	0.000226	CcSEcCtD
Eletriptan—PTGS1—Selenium Micronutrient Network—ICAM1—allergic rhinitis	2.3e-05	0.00528	CbGpPWpGaD
Eletriptan—Asthenia—Betamethasone—allergic rhinitis	2.28e-05	0.000223	CcSEcCtD
Eletriptan—Asthenia—Dexamethasone—allergic rhinitis	2.28e-05	0.000223	CcSEcCtD
Eletriptan—HTR1A—GPCR ligand binding—PTGDR2—allergic rhinitis	2.28e-05	0.00522	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	2.26e-05	0.00519	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—CCL11—allergic rhinitis	2.26e-05	0.00519	CbGpPWpGaD
Eletriptan—Nausea—Prednisolone—allergic rhinitis	2.26e-05	0.000221	CcSEcCtD
Eletriptan—Pruritus—Betamethasone—allergic rhinitis	2.25e-05	0.00022	CcSEcCtD
Eletriptan—Pruritus—Dexamethasone—allergic rhinitis	2.25e-05	0.00022	CcSEcCtD
Eletriptan—Vomiting—Triamcinolone—allergic rhinitis	2.23e-05	0.000218	CcSEcCtD
Eletriptan—Vomiting—Methylprednisolone—allergic rhinitis	2.22e-05	0.000217	CcSEcCtD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	2.22e-05	0.00509	CbGpPWpGaD
Eletriptan—Nausea—Hydrocortisone—allergic rhinitis	2.21e-05	0.000216	CcSEcCtD
Eletriptan—Rash—Triamcinolone—allergic rhinitis	2.21e-05	0.000216	CcSEcCtD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	2.21e-05	0.00506	CbGpPWpGaD
Eletriptan—Dermatitis—Triamcinolone—allergic rhinitis	2.2e-05	0.000216	CcSEcCtD
Eletriptan—Rash—Methylprednisolone—allergic rhinitis	2.2e-05	0.000215	CcSEcCtD
Eletriptan—HTR2B—GPCR ligand binding—CYSLTR1—allergic rhinitis	2.2e-05	0.00505	CbGpPWpGaD
Eletriptan—Dermatitis—Methylprednisolone—allergic rhinitis	2.2e-05	0.000215	CcSEcCtD
Eletriptan—Headache—Triamcinolone—allergic rhinitis	2.19e-05	0.000214	CcSEcCtD
Eletriptan—Headache—Methylprednisolone—allergic rhinitis	2.19e-05	0.000214	CcSEcCtD
Eletriptan—Diarrhoea—Dexamethasone—allergic rhinitis	2.17e-05	0.000212	CcSEcCtD
Eletriptan—Diarrhoea—Betamethasone—allergic rhinitis	2.17e-05	0.000212	CcSEcCtD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	2.16e-05	0.00495	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—CCL11—allergic rhinitis	2.13e-05	0.00487	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.12e-05	0.00485	CbGpPWpGaD
Eletriptan—Dizziness—Dexamethasone—allergic rhinitis	2.1e-05	0.000205	CcSEcCtD
Eletriptan—Dizziness—Betamethasone—allergic rhinitis	2.1e-05	0.000205	CcSEcCtD
Eletriptan—Nausea—Triamcinolone—allergic rhinitis	2.08e-05	0.000203	CcSEcCtD
Eletriptan—Nausea—Methylprednisolone—allergic rhinitis	2.07e-05	0.000203	CcSEcCtD
Eletriptan—CYP2C19—Melatonin metabolism and effects—NFKB1—allergic rhinitis	2.04e-05	0.00469	CbGpPWpGaD
Eletriptan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	2.03e-05	0.00466	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	2.03e-05	0.00465	CbGpPWpGaD
Eletriptan—Vomiting—Betamethasone—allergic rhinitis	2.02e-05	0.000197	CcSEcCtD
Eletriptan—Vomiting—Dexamethasone—allergic rhinitis	2.02e-05	0.000197	CcSEcCtD
Eletriptan—Rash—Betamethasone—allergic rhinitis	2e-05	0.000196	CcSEcCtD
Eletriptan—Rash—Dexamethasone—allergic rhinitis	2e-05	0.000196	CcSEcCtD
Eletriptan—Dermatitis—Betamethasone—allergic rhinitis	2e-05	0.000196	CcSEcCtD
Eletriptan—Dermatitis—Dexamethasone—allergic rhinitis	2e-05	0.000196	CcSEcCtD
Eletriptan—HTR1E—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2e-05	0.00457	CbGpPWpGaD
Eletriptan—Headache—Betamethasone—allergic rhinitis	1.99e-05	0.000194	CcSEcCtD
Eletriptan—Headache—Dexamethasone—allergic rhinitis	1.99e-05	0.000194	CcSEcCtD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—IL10—allergic rhinitis	1.95e-05	0.00448	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	1.94e-05	0.00444	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.92e-05	0.0044	CbGpPWpGaD
Eletriptan—Nausea—Dexamethasone—allergic rhinitis	1.89e-05	0.000184	CcSEcCtD
Eletriptan—Nausea—Betamethasone—allergic rhinitis	1.89e-05	0.000184	CcSEcCtD
Eletriptan—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	1.88e-05	0.00431	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—CCL11—allergic rhinitis	1.86e-05	0.00425	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—IL10—allergic rhinitis	1.83e-05	0.00419	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.81e-05	0.00415	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.79e-05	0.00409	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—IL4—allergic rhinitis	1.78e-05	0.00408	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—CCL11—allergic rhinitis	1.75e-05	0.00401	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.74e-05	0.00398	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—CCL11—allergic rhinitis	1.72e-05	0.00395	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.72e-05	0.00395	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—TAC1—allergic rhinitis	1.69e-05	0.00388	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.69e-05	0.00387	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—TAC1—allergic rhinitis	1.68e-05	0.00385	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.65e-05	0.00377	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—TAC1—allergic rhinitis	1.64e-05	0.00377	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.59e-05	0.00364	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PTGDR2—allergic rhinitis	1.58e-05	0.00361	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PTGDR2—allergic rhinitis	1.57e-05	0.00359	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—TAC1—allergic rhinitis	1.55e-05	0.00354	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PTGDR2—allergic rhinitis	1.53e-05	0.00351	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—TAC1—allergic rhinitis	1.48e-05	0.0034	CbGpPWpGaD
Eletriptan—PTGS1—Selenium Micronutrient Network—NFKB1—allergic rhinitis	1.46e-05	0.00334	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTGDR2—allergic rhinitis	1.45e-05	0.00332	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PTGDR2—allergic rhinitis	1.44e-05	0.0033	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—TAC1—allergic rhinitis	1.4e-05	0.00321	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—IL5—allergic rhinitis	1.38e-05	0.00316	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTGDR2—allergic rhinitis	1.36e-05	0.00313	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.36e-05	0.00312	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.35e-05	0.0031	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—TAC1—allergic rhinitis	1.35e-05	0.00309	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.32e-05	0.00304	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—IL5—allergic rhinitis	1.3e-05	0.00298	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	1.29e-05	0.00295	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—TAC1—allergic rhinitis	1.27e-05	0.00292	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL5—allergic rhinitis	1.25e-05	0.00287	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—TAC1—allergic rhinitis	1.25e-05	0.00287	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.24e-05	0.00285	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.24e-05	0.00283	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.23e-05	0.00282	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.2e-05	0.00276	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CCL11—allergic rhinitis	1.19e-05	0.00274	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CCL11—allergic rhinitis	1.19e-05	0.00272	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL5—allergic rhinitis	1.18e-05	0.00271	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	1.17e-05	0.00268	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CCL11—allergic rhinitis	1.16e-05	0.00266	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CYSLTR1—allergic rhinitis	1.13e-05	0.0026	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	1.13e-05	0.00259	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCL11—allergic rhinitis	1.1e-05	0.00251	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CCL11—allergic rhinitis	1.09e-05	0.0025	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CYSLTR1—allergic rhinitis	1.07e-05	0.00245	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCL11—allergic rhinitis	1.03e-05	0.00237	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	1.01e-05	0.00231	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—TAC1—allergic rhinitis	9.56e-06	0.00219	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	9.55e-06	0.00219	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—TAC1—allergic rhinitis	9.49e-06	0.00218	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTGDR2—allergic rhinitis	9.31e-06	0.00213	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—TAC1—allergic rhinitis	9.3e-06	0.00213	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTGDR2—allergic rhinitis	9.25e-06	0.00212	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	9.16e-06	0.0021	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTGDR2—allergic rhinitis	9.06e-06	0.00208	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—IL5—allergic rhinitis	8.88e-06	0.00204	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCL11—allergic rhinitis	8.85e-06	0.00203	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—IL5—allergic rhinitis	8.83e-06	0.00202	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—TAC1—allergic rhinitis	8.73e-06	0.002	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—TAC1—allergic rhinitis	8.68e-06	0.00199	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—IL5—allergic rhinitis	8.64e-06	0.00198	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—TAC1—allergic rhinitis	8.62e-06	0.00198	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTGDR2—allergic rhinitis	8.51e-06	0.00195	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—TAC1—allergic rhinitis	8.44e-06	0.00194	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL5—allergic rhinitis	8.12e-06	0.00186	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL5—allergic rhinitis	8.07e-06	0.00185	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL5—allergic rhinitis	8.01e-06	0.00184	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TAC1—allergic rhinitis	7.96e-06	0.00183	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—TAC1—allergic rhinitis	7.93e-06	0.00182	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL5—allergic rhinitis	7.85e-06	0.0018	CbGpPWpGaD
Eletriptan—CYP2A6—NRF2 pathway—TGFB1—allergic rhinitis	7.66e-06	0.00176	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TAC1—allergic rhinitis	7.51e-06	0.00172	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	7.45e-06	0.00171	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL5—allergic rhinitis	7.4e-06	0.0017	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL5—allergic rhinitis	7.37e-06	0.00169	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CYSLTR1—allergic rhinitis	7.3e-06	0.00167	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CYSLTR1—allergic rhinitis	7.26e-06	0.00166	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CYSLTR1—allergic rhinitis	7.11e-06	0.00163	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—TAC1—allergic rhinitis	7.08e-06	0.00162	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL11—allergic rhinitis	7.06e-06	0.00162	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL11—allergic rhinitis	7.01e-06	0.00161	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL5—allergic rhinitis	6.98e-06	0.0016	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTGDR2—allergic rhinitis	6.9e-06	0.00158	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL11—allergic rhinitis	6.86e-06	0.00157	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CYSLTR1—allergic rhinitis	6.68e-06	0.00153	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL5—allergic rhinitis	6.58e-06	0.00151	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL11—allergic rhinitis	6.45e-06	0.00148	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TAC1—allergic rhinitis	6.43e-06	0.00147	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL5—allergic rhinitis	5.98e-06	0.00137	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	5.41e-06	0.00124	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL11—allergic rhinitis	5.23e-06	0.0012	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SMAD3—allergic rhinitis	5.21e-06	0.00119	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TAC1—allergic rhinitis	5.13e-06	0.00118	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TAC1—allergic rhinitis	5.09e-06	0.00117	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TAC1—allergic rhinitis	4.99e-06	0.00114	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SMAD3—allergic rhinitis	4.92e-06	0.00113	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL5—allergic rhinitis	4.77e-06	0.00109	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL5—allergic rhinitis	4.73e-06	0.00109	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TAC1—allergic rhinitis	4.68e-06	0.00107	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL5—allergic rhinitis	4.64e-06	0.00106	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	4.42e-06	0.00101	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL5—allergic rhinitis	4.35e-06	0.000998	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TAC1—allergic rhinitis	3.8e-06	0.000871	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.68e-06	0.000843	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL5—allergic rhinitis	3.53e-06	0.00081	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SMAD3—allergic rhinitis	3.35e-06	0.000769	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SMAD3—allergic rhinitis	3.33e-06	0.000764	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SMAD3—allergic rhinitis	3.26e-06	0.000748	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SMAD3—allergic rhinitis	3.06e-06	0.000703	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NFKB1—allergic rhinitis	2.65e-06	0.000607	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NFKB1—allergic rhinitis	2.5e-06	0.000573	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SMAD3—allergic rhinitis	2.49e-06	0.00057	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TGFB1—allergic rhinitis	2.21e-06	0.000506	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TGFB1—allergic rhinitis	2.08e-06	0.000477	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NFKB1—allergic rhinitis	1.7e-06	0.000391	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NFKB1—allergic rhinitis	1.69e-06	0.000388	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NFKB1—allergic rhinitis	1.66e-06	0.00038	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NFKB1—allergic rhinitis	1.56e-06	0.000357	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—allergic rhinitis	1.42e-06	0.000326	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—allergic rhinitis	1.41e-06	0.000323	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—allergic rhinitis	1.38e-06	0.000317	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—allergic rhinitis	1.3e-06	0.000298	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NFKB1—allergic rhinitis	1.26e-06	0.00029	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—allergic rhinitis	1.05e-06	0.000241	CbGpPWpGaD
